346 related articles for article (PubMed ID: 26168639)
1. [SECONDARY PREVENTION IN PATIENTS WITH ACUTE CORONARY SYNDROME HOSPITALIZED IN INTERNAL MEDICINE DEPARTMENTS].
Yahia DH; Pereg D; Lishner M; Elis A
Harefuah; 2015 May; 154(5):299-302, 339-40. PubMed ID: 26168639
[TBL] [Abstract][Full Text] [Related]
2. Utilization of Evidence-Based Secondary Prevention Medications at the Time of Discharge in Patients with Acute Coronary Syndrome (ACS) in Qatar.
El-Hajj MS; Saad A; Al-Suwaidi J; Al-Marridi WZ; Elkhalifa DH; Mohamed AA; Mahfoud ZR
Curr Vasc Pharmacol; 2016; 14(4):394-403. PubMed ID: 26916397
[TBL] [Abstract][Full Text] [Related]
3. Decade-Long Trends (2001 to 2011) in the Use of Evidence-Based Medical Therapies at the Time of Hospital Discharge for Patients Surviving Acute Myocardial Infarction.
Makam RC; Erskine N; McManus DD; Lessard D; Gore JM; Yarzebski J; Goldberg RJ
Am J Cardiol; 2016 Dec; 118(12):1792-1797. PubMed ID: 27743577
[TBL] [Abstract][Full Text] [Related]
4. Use of secondary prevention drug therapy in patients with acute coronary syndrome after hospital discharge.
Lee HY; Cooke CE; Robertson TA
J Manag Care Pharm; 2008 Apr; 14(3):271-80. PubMed ID: 18439049
[TBL] [Abstract][Full Text] [Related]
5. Hospital revascularisation capability and quality of care after an acute coronary syndrome in Switzerland.
Welker J; Auer R; Gencer B; Muller O; Cornuz J; Matter CM; Mach F; Windecker S; Rodondi N; Nanchen D
Swiss Med Wkly; 2016; 146():w14275. PubMed ID: 26859223
[TBL] [Abstract][Full Text] [Related]
6. Optimizing prevention and guideline-concordant care in Montenegro.
Knežević B; Musić L; Batrićević G; Bošković A; Bulatović N; Nenezić A; Vujović J; Kalezić M
Int J Cardiol; 2016 Aug; 217 Suppl():S32-6. PubMed ID: 27381861
[TBL] [Abstract][Full Text] [Related]
7. Rationale and design of a randomized cluster trial to improve guideline-adherence of secondary preventive drugs prescription after coronary artery bypass grafting in China: Measurement and Improvement Studies of Surgical Coronary Revascularization: Secondary Prevention (MISSION-1) Study.
Rao C; Du J; Li X; Li J; Zhang H; Zhao Y; Hu S; Jiang L; Zheng Z;
Am Heart J; 2016 Aug; 178():9-18. PubMed ID: 27502847
[TBL] [Abstract][Full Text] [Related]
8. Utilization of evidence-based therapy for the secondary prevention of acute coronary syndromes in Australian practice.
Vermeer NS; Bajorek BV
J Clin Pharm Ther; 2008 Dec; 33(6):591-601. PubMed ID: 19138236
[TBL] [Abstract][Full Text] [Related]
9. Self-reported use of evidence-based medicine and smoking cessation 6 - 9 months after acute coronary syndrome: a single-centre perspective.
Griffiths B; Lesosky M; Ntsekhe M
S Afr Med J; 2014 Jun; 104(7):483-7. PubMed ID: 25214049
[TBL] [Abstract][Full Text] [Related]
10. The impact of pharmacist-initiated interventions in improving acute coronary syndrome secondary prevention pharmacotherapy prescribing upon discharge.
Hassan Y; Kassab Y; Abd Aziz N; Akram H; Ismail O
J Clin Pharm Ther; 2013 Apr; 38(2):97-100. PubMed ID: 23441979
[TBL] [Abstract][Full Text] [Related]
11. Treatment outcome of acute coronary syndrome patients admitted to Ayder Comprehensive Specialized Hospital, Mekelle, Ethiopia; A retrospective cross-sectional study.
Desta DM; Nedi T; Hailu A; Atey TM; Tsadik AG; Asgedom SW; Kasahun GG; Ayalew E
PLoS One; 2020; 15(2):e0228953. PubMed ID: 32053702
[TBL] [Abstract][Full Text] [Related]
12. Comparison of characteristics, management practices, and outcomes of patients between the global registry and the gulf registry of acute coronary events.
Awad HH; Zubaid M; Alsheikh-Ali AA; Al Suwaidi J; Anderson FA; Gore JM; Goldberg RJ
Am J Cardiol; 2011 Nov; 108(9):1252-8. PubMed ID: 21880292
[TBL] [Abstract][Full Text] [Related]
13. Longitudinal persistence with secondary prevention therapies relative to patient risk after myocardial infarction.
Shore S; Jones PG; Maddox TM; Bradley SM; Stolker JM; Arnold SV; Parashar S; Peterson P; Bhatt DL; Spertus J; Ho PM
Heart; 2015 May; 101(10):800-7. PubMed ID: 25801001
[TBL] [Abstract][Full Text] [Related]
14. Optimal secondary prevention medication use in acute myocardial infarction patients with nonobstructive coronary artery disease is modified by management strategy: insights from the TRIUMPH Registry.
Pitts R; Daugherty SL; Tang F; Jones P; Ho PM; Tsai TT; Spertus J; Maddox TM
Clin Cardiol; 2017 Jun; 40(6):347-355. PubMed ID: 28387960
[TBL] [Abstract][Full Text] [Related]
15. Prescription Rates of Guideline-Directed Medications Are Associated With In-Hospital Mortality Among Japanese Patients With Acute Myocardial Infarction: A Report From JROAD - DPC Study.
Nakao K; Yasuda S; Nishimura K; Noguchi T; Nakai M; Miyamoto Y; Sumita Y; Shishido T; Anzai T; Ito H; Tsutsui H; Saito Y; Komuro I; Ogawa H
J Am Heart Assoc; 2019 Apr; 8(7):e009692. PubMed ID: 30909774
[TBL] [Abstract][Full Text] [Related]
16. Receipt of cardiac medications upon discharge among men and women with acute coronary syndrome and nonobstructive coronary artery disease.
Ramanath VS; Armstrong DF; Grzybowski M; Rahnama-Mohagdam S; Tamhane UU; Gordon K; Froehlich JB; Eagle KA; Jackson EA
Clin Cardiol; 2010 Jan; 33(1):36-41. PubMed ID: 20063300
[TBL] [Abstract][Full Text] [Related]
17. Use of evidence-based management for acute coronary syndrome.
Tang E; Wong CK; Wilkins G; Herbison P; Williams M; Kay P; Restieaux N
N Z Med J; 2005 Oct; 118(1223):U1678. PubMed ID: 16224502
[TBL] [Abstract][Full Text] [Related]
18. Under-use of secondary prevention medication in acute coronary syndrome patients treated with in-hospital coronary artery bypass graft surgery.
Looi KL; Chow KL; Looi JL; Lee M; Halliday S; White H; Ellis C
N Z Med J; 2011 Sep; 124(1343):18-27. PubMed ID: 21964009
[TBL] [Abstract][Full Text] [Related]
19. In-hospital prescriptions of secondary-prevention medications for post-acute coronary syndrome patients in South Korea
.
Kang HB; Choi M; Yoon SG; Cho YS; Je NK
Int J Clin Pharmacol Ther; 2018 Jan; 56(1):1-11. PubMed ID: 29168689
[TBL] [Abstract][Full Text] [Related]
20. Secondary prevention of coronary artery disease in contemporary clinical practice.
Jankowski P; Czarnecka D; Wolfshaut-Wolak R; Łysek R; Łukaszewska A; Bogacki P; Grodecki J; Mirek-Bryniarska E; Nessler J; Podolec P; Kawecka-Jaszcz K; Pająk A
Cardiol J; 2015; 22(2):219-26. PubMed ID: 25299500
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
